Vidarabine (Monohydrate) Overview Categories 6 Anti-infective drugs6.5 Antivirals, systemic6.5.1 Herpes and cytomegalovirus infection 21 Ophthalmological preparations21.1 Anti-infectives21.1.2 Antivirals Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Vidarabine (Monohydrate) Manufacturers of Vidarabine (Monohydrate) Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Vidarabine (Monohydrate)'s dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 0.833 to 1.25 mg/kg.hr1 (1.0415)24 hourlyIV InfFor 12 Hours in a Day3 %3 (3)4.8 hourlyOphthalmicAs Required Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Vidarabine (Monohydrate) is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Famotidine is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Famotidine Back to top Manufacturers of Vidarabine (Monohydrate) in Pakistan Back to top Previous Drug Generic - Next Drug Generic